Posted by ABMN Staff on May 16th, 2024
Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) saw a large growth in short interest in April. As of April 30th, there was short interest totalling 3,390,000 shares, a growth of 7.6% from the April 15th total of 3,150,000...
More of this article »